APA (7th ed.) Citation

Beelen, D. W., Iacobelli, S., Koster, L., Eikema, D., van Biezen, A., Stölzel, F., . . . Mohty, M. (2024). Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients: A clinical trial to registry data comparison. Bone marrow transplantation, 59(5), . https://doi.org/10.1038/s41409-024-02241-2

Chicago Style (17th ed.) Citation

Beelen, Dietrich W., et al. "Fludarabine-treosulfan Versus Fludarabine-melphalan or Busulfan-cyclophosphamide Conditioning in Older AML or MDS Patients: A Clinical Trial to Registry Data Comparison." Bone Marrow Transplantation 59, no. 5 (2024). https://doi.org/10.1038/s41409-024-02241-2.

MLA (9th ed.) Citation

Beelen, Dietrich W., et al. "Fludarabine-treosulfan Versus Fludarabine-melphalan or Busulfan-cyclophosphamide Conditioning in Older AML or MDS Patients: A Clinical Trial to Registry Data Comparison." Bone Marrow Transplantation, vol. 59, no. 5, 2024, https://doi.org/10.1038/s41409-024-02241-2.